Claims for Patent: 8,435,545

Summary for Patent: 8,435,545

Title:	Capsule having broad color spectrum
Abstract:	The present invention is directed to a capsule comprising a water-soluble compound suitable for the capsule, and a mixture of colorant agents, wherein the color of the capsule may be in the range of 15<L<90; -30<a<+75; -37<b<+46 as measured in accordance with the Lab color space. The present invention further includes capsules containing a filling such as food, medicine, cosmetics, agrichemicals, feed or active biological ingredient.
Inventor(s):	Murray; Cale E. (Browns Summit, NC)
Assignee:	Qualicaps, Inc. (Whitsett, NC)
Application Number:	13/223,540
Patent Claims:	1. A capsule comprising: a) a water-soluble compound suitable for the capsule, b) a mixture of colorant agents comprising up to about 0.35 wt % of iron oxide yellow, up to about 0.24 wt % of iron oxide black, up to about 0.70 wt % of iron oxide red, up to about 1.92 wt % of titanium dioxide, up to about 0.23 wt % of FD&C Blue No 1, up to about 0.04 wt % of FD&C Blue No 2, up to about 0.09 wt % of FD&C Yellow No 6, up to about 0.23 wt % of FD&C Yellow No 5, up to about 0.35 wt % of FD&C Red No 40, up to about 0.23 wt % of FD&C Red No 3, up to about 0.12 wt % of D&C Red No 22, up to about 0.05 wt % of D&C Red No 33, up to about 0.16 wt % of D&C Red No 28, up to about 0.06 wt % of FD&C Green No 3, and up to about 0.09 wt % of D&C Yellow No 10; and c) an edible ink imprinted on the capsule. 2. The capsule according to claim 1 wherein the color of the capsule may be in the range of 15<L<90; -30<a<+75; -37<b<+46 as measured in accordance with the Lab color space. 3. The capsule according to claim 1 wherein the water-soluble compound is selected from gelatin or cellulose compound and the gelatin is substituted with hydroxypropyl methylcellulose. 4. The capsule according to claim 1 further comprising a gelling agent. 5. The capsule according to claim 4 wherein the gelling agent is at least one member selected from carrageenan, pectin, xanthan gum, locust bean gum, tamarind seed polysaccharide, curdlan, gelatin, fur selenium, agar, and gellan gum. 6. The capsule according to claim 4 wherein the gelling agent is carrageenan. 7. The capsule according to claim 1 wherein the capsule is imprinted with at least two edible inks. 8. The capsule according to claim 1 contains a filling. 9. The capsule according to claim 8, wherein the filling is food, medicine, cosmetics, agrichemicals, feed or an active biological ingredient. 10. The capsule according to claim 8 wherein the filling is selected from the group consisting of: nourishment tonics, antipyretics/analgesics/anti-inflammatory drugs, psychotropic drugs, anti-anxiety drugs, antidepressant drugs, hypnotic/sedative drugs, antispasmodic drugs, drugs acting on the central nervous system, cerebral metabolism improvers, cerebral circulation improvers, antiepileptic drugs, sympathetic nerve stimulants, digestives, antacids, antiulcer drugs, antitussive/expectorant drugs, antiemetic drugs, respiration promoters, bronchodilators, antiallergic drugs, drugs for dentistry and oral cavity, antihistamic drugs, cardiotonic drugs, antiarrhythmic drugs, diuretic drugs, antihypertensive drugs, vasoconstrictors, coronary vasodilators, peripheral vasodilators, antihyperlipidemic drugs, cholagogues, antibiotics, chemotherapeutic drugs, antidiabetic drugs; antiosteoporotic drugs, antirheumatic drugs, skeletal muscle relaxants, spasmolytic drugs, hormone preparations, alkaloid narcotics, sulfa drugs, anti-gout drugs, anticoagulant drugs, antineoplastic drugs, growth hormones, human growth hormones, recombinant human growth hormones, bovine growth hormones, porcine growth hormones, growth hormone releasing hormones, growth hormone releasing factor; interferons, alpha-interferon, beta-interferon, gamma-interferon; interleukin, interleukin-1, interleukin-2; insulin porcine insulin, bovine insulin, human insulin, human recombinant insulin, insulin-like growth factor, insulin-like growth factor-1; heparin unfractionated heparin, heparinoids, dermatans, chondroitins, low molecular weight heparin, very low molecular weight heparin, ultra low molecular weight heparin; calcitonin salmon calcitonin, eel calcitonin, human calcitonin; erythropoietin; atrial naturetic factor; antigens; monoclonal antibodies; somatostatin; protease inhibitors; adrenocorticotropin; gonadotropin releasing hormone; oxytocin; leutinizing-hormone-releasing-hormone; follicle stimulating hormone; glucocerebrosidase; thrombopoietin; filgrastim; prostaglandins; cyclosporin; vasopressin; cromolyn sodium; sodium chromoglycate; disodium chromoglycate; vancomycin; desferrioxamine; parathyroid hormone; fragments of parathyroid hormone; antimicrobials; anti-fungal agents; vitamins; and any combination thereof. 11. A capsule comprising: a) a water-soluble compound suitable for the capsule, b) a mixture of colorant agents comprising colors up to about 0.24 wt % of E172(i), up to about 0.70 wt % of E172(ii), up to about 0.35 wt % of E172(iii), up to about 1.92 wt % of E171, up to about 0.23 wt % of E133, up to about 0.09 wt % of E110, up to about 0.35 wt % of E129; E131; E123, E122, E150, E120, E124, E140, E129, up to about 0.23 wt % of E127, up to about 0.04 wt % of E132, up to about 0.23 wt % of E102; up to about 0.06 wt % of E143; and E151, and c) an edible ink imprinted on the capsule. 12. The capsule according to claim 11 wherein the color of the capsule may be in the range of 15<L<90; -30<a<+75; -37<b<+46 as measured in accordance with the Lab color space. 13. The capsule according to claim 11 wherein the water-soluble compound is selected from gelatin or cellulose compound and the gelatin is substituted with hydroxypropyl methylcellulose. 14. The capsule according to claim 11 further comprising a gelling agent. 15. The capsule according to claim 14 wherein the gelling agent is at least one member selected from carrageenan, pectin, xanthan gum, locust bean gum, tamarind seed polysaccharide, curdlan, gelatin, fur selenium, agar, and gellan gum. 16. The capsule according to claim 14 wherein the gelling agent is carrageenan. 17. The capsule according to claim 11 wherein the capsule is imprinted with at least two edible inks. 18. The capsule according to claim 11 contains a filling. 19. The capsule according to claim 18, wherein the filling is food, medicine, cosmetics, agrichemicals, feed or an active biological ingredient. 20. The capsule according to claim 18 wherein the filling is selected from the group consisting of: nourishment tonics, antipyretics/analgesics/anti-inflammatory drugs, psychotropic drugs, anti-anxiety drugs, antidepressant drugs, hypnotic/sedative drugs, antispasmodic drugs, drugs acting on the central nervous system, cerebral metabolism improvers, cerebral circulation improvers, antiepileptic drugs, sympathetic nerve stimulants, digestives, antacids, antiulcer drugs, antitussive/expectorant drugs, antiemetic drugs, respiration promoters, bronchodilators, antiallergic drugs, drugs for dentistry and oral cavity, antihistamic drugs, cardiotonic drugs, antiarrhythmic drugs, diuretic drugs, antihypertensive drugs, vasoconstrictors, coronary vasodilators, peripheral vasodilators, antihyperlipidemic drugs, cholagogues, antibiotics, chemotherapeutic drugs, antidiabetic drugs; antiosteoporotic drugs, antirheumatic drugs, skeletal muscle relaxants, spasmolytic drugs, hormone preparations, alkaloid narcotics, sulfa drugs, anti-gout drugs, anticoagulant drugs, antineoplastic drugs, growth hormones, human growth hormones, recombinant human growth hormones, bovine growth hormones, porcine growth hormones, growth hormone releasing hormones, growth hormone releasing factor; interferons, alpha-interferon, beta-interferon, gamma-interferon; interleukin, interleukin-1, interleukin-2; insulin porcine insulin, bovine insulin, human insulin, human recombinant insulin, insulin-like growth factor, insulin-like growth factor-1; heparin unfractionated heparin, heparinoids, dermatans, chondroitins, low molecular weight heparin, very low molecular weight heparin, ultra low molecular weight heparin; calcitonin salmon calcitonin, eel calcitonin, human calcitonin; erythropoietin; atrial naturetic factor; antigens; monoclonal antibodies; somatostatin; protease inhibitors; adrenocorticotropin; gonadotropin releasing hormone; oxytocin; leutinizing-hormone-releasing-hormone; follicle stimulating hormone; glucocerebrosidase; thrombopoietin; filgrastim; prostaglandins; cyclosporin; vasopressin; cromolyn sodium; sodium chromoglycate; disodium chromoglycate; vancomycin; desferrioxamine; parathyroid hormone; fragments of parathyroid hormone; antimicrobials; anti-fungal agents; vitamins; and any combination thereof.

Details for Patent 8,435,545

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Eli Lilly And Company	HUMULIN R U-100	insulin human	Injection	018780	10/28/1982		2039-02-26
Eli Lilly And Company	HUMULIN R U-500	insulin human	Injection	018780	12/29/2015		2039-02-26
Eli Lilly And Company	HUMULIN R U-100	insulin human	Injection	018780	08/06/1998		2039-02-26